<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Abstract

The magnitude and the characteristics of the use of methamphetamine, MDMA (Ecstasy), LSD (d-lysergic acid diethylamide), ketamine, GHB (gamma-hydroxybutyrate), and flunitrazepam (Rohypnol) were examined in a probability sample of the U.S. civilian population that included multiethnic urban, suburban, and rural youths aged 16-23 (N=19,084).Data were drawn from the National Survey on Drug Use and Health (NSDUH). Logistic regression analyses were conducted to identify the characteristics associated with the use of each of these drugs and of multiple drugs.Approximately 20% of youths aged 16-23 reported having ever used one or more of these drugs. Less than 1% of club drug users used club drugs only, and 82% of them had ever used three or more drug classes. Females were more likely than males to report using multiple club drugs. Recent users of methamphetamine were most likely to be females and adolescents aged 16 or 17. Recent users of MDMA tended to be young adults aged 18-21 and residents of metropolitan areas. Most recent users of LSD were adolescents aged 16-19 and those in low-income families. Ketamine users were primarily employed youths. Staying in school and getting married were associated with decreased odds of club drug use. Club drug use was highly associated with the presence of criminal behaviors and recent alcohol abuse or dependence.Adolescents are more likely than young adults to use multiple drugs. The clustering of multidrug use and alcohol use disorder is a cause of concern.

Description

Subjects

Humans, Substance-Related Disorders, Methamphetamine, N-Methyl-3,4-methylenedioxyamphetamine, Sodium Oxybate, Ketamine, Lysergic Acid Diethylamide, Flunitrazepam, Data Collection, Incidence, Prevalence, Age of Onset, Demography, Adolescent, Adult, Female, Male

Citation

Published Version (Please cite this version)

10.1016/j.drugalcdep.2006.01.002

Publication Info

Wu, Li-Tzy, William E Schlenger and Deborah M Galvin (2006). Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug and alcohol dependence, 84(1). pp. 102–113. 10.1016/j.drugalcdep.2006.01.002 Retrieved from https://hdl.handle.net/10161/20041.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Endorsement

Review

Supplemented By

Referenced By

Scholars@Duke

Wu

Li-Tzy Wu

Professor in Psychiatry and Behavioral Sciences

Education/Training:

 

Pre- and post-doctoral training in mental health service research, psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns Hopkins University School of Public Health

 

Fellow of the NIH Summer Institute on the Design and Conduct of Randomized Clinical Trials

 


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.